/Moderna%20Inc%20HQ-by%20hapabapa%20via%20iStock.jpg)
Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.
Discounted stock prices make these strong brands worth considering as investments.
The biotech is proving that it's not a pandemic stock.
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement...
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine
Stocks that traded heavily or had substantial price changes on Tuesday: Tesla, Archer Aviation rise; Eli Lilly falls
US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine
September Nasdaq 100 E-Mini futures (NQU24) are trending down -0.23% this morning as an underwhelming sales forecast from chipmaker Micron weighed on sentiment, while investors awaited a flurry of U.S....
These stocks have suffered as the demand for their biggest product -- the coronavirus vaccine -- waned.
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. Stock indexes on...